Annexin Pharmaceuticals AB (publ) (STO:ANNX)

STO:ANNX Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36.88	16.34	21.42	31.11	49.48	18.13
Cash & Short-Term Investments	36.88	16.34	21.42	31.11	49.48	18.13
Cash Growth	43.82%	-23.71%	-31.17%	-37.12%	172.88%	325.33%
Other Receivables	0.39	0.42	2.63	1.86	1.02	0.28
Receivables	0.39	0.42	2.63	1.86	1.02	0.28
Inventory	-	-	-	-	-	4.28
Prepaid Expenses	0.61	0.63	0.87	0.67	0.22	0.2
Total Current Assets	37.87	17.38	24.92	33.65	50.72	22.9
Property, Plant & Equipment	1.14	1.08	1.17	1.26	1.35	1.44
Long-Term Investments	0.31	0.31	0.31	0.41	0.15	0.15
Other Intangible Assets	0.19	0.27	0.37	0.47	0.58	0.68
Other Long-Term Assets	0	-	-	0.89	-	-
Total Assets	39.51	19.04	26.76	36.68	52.79	25.16
Accounts Payable	1.54	2.96	4.33	3.33	3.51	2.9
Accrued Expenses	2.2	1.98	3.3	2.43	1.7	1.42
Other Current Liabilities	0.32	0.39	0.32	0.77	0.84	0.2
Total Current Liabilities	4.06	5.32	7.95	6.53	6.06	4.52
Total Liabilities	4.06	5.32	7.95	6.53	6.06	4.52
Common Stock	11.68	8.82	5.74	2.56	27.45	21.22
Additional Paid-In Capital	386.61	341.36	299.29	269.63	220.91	148.91
Retained Earnings	-362.84	-336.46	-286.21	-242.16	-201.63	-149.49
Comprehensive Income & Other	-	-	-	0.12	-	-
Shareholders' Equity	35.45	13.71	18.81	30.15	46.73	20.64
Total Liabilities & Equity	39.51	19.04	26.76	36.68	52.79	25.16
Net Cash (Debt)	36.88	16.34	21.42	31.11	49.48	18.13
Net Cash Growth	43.82%	-23.71%	-31.17%	-37.12%	172.88%	349.26%
Net Cash Per Share	5.96	3.61	12.82	21.27	60.31	29.48
Filing Date Shares Outstanding	7.06	5.33	3.47	1.54	1.37	0.71
Total Common Shares Outstanding	7.06	5.33	3.47	1.54	1.37	0.71
Working Capital	33.81	12.06	16.97	27.12	44.66	18.38
Book Value Per Share	5.02	2.57	5.43	19.52	34.05	29.18
Tangible Book Value	35.26	13.45	18.44	29.68	46.15	19.96
Tangible Book Value Per Share	4.99	2.52	5.32	19.21	33.63	28.22

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.